Pure Global AI
NCT06154356Not yet recruiting

Action Observation and Motor Imagery Therapy in Parkinson's Disease

Effect of Action Observation and Motor Imagery Therapy on Balance, Functional Status and Quality of Life in Parkinson's Disease, Randomized Controlled Trial
Karamanoğlu Mehmetbey UniversityClinicalTrials.govother
Study focus
Disease/Condition
Parkinson's Disease
Drug/Device/Intervention
Action observation and motor imagery therapy for rehabilitation
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Karamanoğlu Mehmetbey University
Location
Karaman, Turkey
Timeline & enrollment
Phase
N/A
Start date
Nov 30, 2023
End date
Dec 01, 2024
Enrollment
54 participants
Primary outcome

The difference in the scores of the Berg Balance Scale between pre- and post-rehabilitation assessments,The difference in the scores of the Unified Parkinson's Disease Rating Scale (UPDRS) between pre- and post-rehabilitation assessments,The difference in the scores of the Timed Up and Go Test (TUG) between pre- and post-rehabilitation assessments,The difference in the scores of the Five Times Sit to Stand Test between pre- and post-rehabilitation assessments

Summary

In recent years, motor imagery (MI) and action observation (AO) therapy strategies have been
 used in rehabilitation programs to increase motor learning in Parkinson's disease (PD).
 Visuomotor training strategies such as AO and MI therapy rely on the activity of the mirror
 neuron system to facilitate motor re-learning. Mirror neurons are activated during the
 performance of goal-directed actions, also when observing the same action and visualizing the
 action in the mind.
 
 The aim of this clinical trial is to test whether the application of AO and MI treatment in
 PD in addition to conventional rehabilitation programs has an additional effect on Balance,
 Functional Status and Quality of Life.

ICD-10 classifications
Parkinson diseaseParkinsonism in diseases classified elsewhereDementia in Parkinson diseaseSecondary parkinsonismPostencephalitic parkinsonism
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06154356
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06154356 through Pure Global AI's free database. This phase not specified trial is sponsored by Karamanoğlu Mehmetbey University and is currently Not yet recruiting. The study focuses on Parkinson's Disease. Target enrollment is 54 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.